Research and Development Expense of Enovis CORP from 02 Jul 2010 to 03 Oct 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.
Summary
Enovis CORP quarterly and annual Research and Development Expense in USD history and change rate from 02 Jul 2010 to 03 Oct 2025.
  • Enovis CORP Research and Development Expense for the quarter ending 03 Oct 2025 was $29,739,000, a 45% increase year-over-year.
  • Enovis CORP Research and Development Expense for the twelve months ending 03 Oct 2025 was $112,918,000, a 32% increase year-over-year.
  • Enovis CORP annual Research and Development Expense for 2024 was $91,298,000, a 21% increase from 2023.
  • Enovis CORP annual Research and Development Expense for 2023 was $75,331,000, a 24% increase from 2022.
  • Enovis CORP annual Research and Development Expense for 2022 was $60,827,000, a 24% increase from 2021.
Source SEC data
View on sec.gov
Research and Development Expense, Trailing 12 Months (USD)
Research and Development Expense, Quarterly (USD)
Research and Development Expense, YoY Quarterly Change (%)
Research and Development Expense, Annual (USD)
Research and Development Expense, YoY Annual Change (%)

Enovis CORP Quarterly Research and Development Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $112,918,000 $29,739,000 +$9,248,000 +45% 05 Jul 2025 03 Oct 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $103,670,000 $30,700,000 +$7,221,000 +31% 05 Apr 2025 04 Jul 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $96,449,000 $28,528,000 +$5,151,000 +22% 01 Jan 2025 04 Apr 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $91,298,000 $23,951,000 +$5,632,000 +31% 28 Sep 2024 31 Dec 2024 10-K 26 Feb 2025 2024 FY
Q3 2024 $85,666,000 $20,491,000 +$590,000 +3% 29 Jun 2024 27 Sep 2024 10-Q 06 Nov 2025 2025 Q3
Q2 2024 $85,076,000 $23,479,000 +$4,561,000 +24% 30 Mar 2024 28 Jun 2024 10-Q 07 Aug 2025 2025 Q2
Q1 2024 $80,515,000 $23,377,000 +$5,184,000 +28% 01 Jan 2024 29 Mar 2024 10-Q 08 May 2025 2025 Q1
Q4 2023 $75,331,000 $18,319,000 +$3,594,000 +24% 30 Sep 2023 31 Dec 2023 10-K 26 Feb 2025 2024 FY
Q3 2023 $71,737,000 $19,901,000 +$4,302,000 +28% 01 Jul 2023 29 Sep 2023 10-Q 06 Nov 2024 2024 Q3
Q2 2023 $67,435,000 $18,918,000 +$3,257,000 +21% 01 Apr 2023 30 Jun 2023 10-Q 07 Aug 2024 2024 Q2
Q1 2023 $64,178,000 $18,193,000 +$3,351,000 +23% 01 Jan 2023 31 Mar 2023 10-Q 02 May 2024 2024 Q1
Q4 2022 $60,827,000 $14,725,000 +$9,028,000 +158% 01 Oct 2022 31 Dec 2022 10-K 26 Feb 2025 2024 FY
Q3 2022 $51,799,000 $15,599,000 +$3,141,000 +25% 02 Jul 2022 30 Sep 2022 10-Q 07 Nov 2023 2023 Q3
Q2 2022 $48,658,000 $15,661,000 +$4,622,000 +42% 02 Apr 2022 01 Jul 2022 10-Q 03 Aug 2023 2023 Q2
Q1 2022 $44,036,000 $14,842,000 -$5,058,000 -25% 01 Jan 2022 01 Apr 2022 10-Q 04 May 2023 2023 Q1
Q4 2021 $49,094,000 $5,697,000 +$20,829,000 02 Oct 2021 31 Dec 2021 10-K 22 Feb 2024 2023 FY
Q3 2021 $28,265,000 $12,458,000 -$4,342,000 -26% 03 Jul 2021 01 Oct 2021 10-Q 02 Nov 2022 2022 Q3
Q2 2021 $32,607,000 $11,039,000 -$3,061,000 -22% 03 Apr 2021 02 Jul 2021 10-Q 04 Aug 2022 2022 Q2
Q1 2021 $35,668,000 $19,900,000 +$1,400,000 +7.6% 01 Jan 2021 02 Apr 2021 10-Q 10 May 2022 2022 Q1
Q4 2020 $34,268,000 $15,132,000 03 Oct 2020 31 Dec 2020 10-K 01 Mar 2023 2022 FY
Q3 2020 $16,800,000 +$500,000 +3.1% 04 Jul 2020 02 Oct 2020 10-Q 04 Nov 2021 2021 FY
Q2 2020 $14,100,000 -$18,500,000 -57% 04 Apr 2020 03 Jul 2020 10-Q 28 Jul 2021 2021 FY
Q1 2020 $18,500,000 01 Jan 2020 03 Apr 2020 10-Q 29 Apr 2021 2021 FY
Q3 2019 $16,300,000 29 Jun 2019 27 Sep 2019 10-Q 29 Oct 2020 2020 Q3
Q2 2019 $32,600,000 30 Mar 2019 28 Jun 2019 10-Q 06 Aug 2020 2020 Q2
Q3 2011 $1,439,000 -$144,000 -9.1% 02 Jul 2011 30 Sep 2011 10-Q 27 Oct 2011 2011 Q3
Q2 2011 $1,493,000 -$27,000 -1.8% 02 Apr 2011 01 Jul 2011 10-Q 29 Jul 2011 2011 Q2
Q3 2010 $1,583,000 03 Jul 2010 01 Oct 2010 10-Q 27 Oct 2011 2011 Q3
Q2 2010 $1,520,000 03 Apr 2010 02 Jul 2010 10-Q 29 Jul 2011 2011 Q2

Enovis CORP Annual Research and Development Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $91,298,000 +$15,967,000 +21% 01 Jan 2024 31 Dec 2024 10-K 26 Feb 2025 2024 FY
2023 $75,331,000 +$14,504,000 +24% 01 Jan 2023 31 Dec 2023 10-K 26 Feb 2025 2024 FY
2022 $60,827,000 +$11,733,000 +24% 01 Jan 2022 31 Dec 2022 10-K 26 Feb 2025 2024 FY
2021 $49,094,000 +$14,826,000 +43% 01 Jan 2021 31 Dec 2021 10-K 22 Feb 2024 2023 FY
2020 $34,268,000 01 Jan 2020 31 Dec 2020 10-K 01 Mar 2023 2022 FY
2011 $5,707,000 -$498,000 -8% 01 Jan 2011 31 Dec 2011 10-K 23 Feb 2012 2011 FY
2010 $6,205,000 01 Jan 2010 31 Dec 2010 10-K 23 Feb 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.